RFA-DA-25-060-Full-Announcement.html

This document provides details on a federal grant opportunity notice titled "High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)" with the solicitation number RFA-DA-25-060. The National Institutes of Health within the Department of Health and Human Services is seeking applications for innovative research projects exploring the intersection of HIV and substance use. Eligible applicants include higher education institutions, small businesses, non-profits, tribal organizations, and state and local governments. The funding will support both individual investigators and research teams across basic science, clinical research, and implementation studies. All proposals must align with NIH's HIV/AIDS research priorities and focus on prevention, treatment, or a cure for HIV among people who use drugs. Awards will be made under the Drug Abuse and Addiction Research Programs grant program with the CFDA number 93.279 to fund neuroscience, biomedical, behavioral, epidemiological, health services, and health disparities research. Applications are due based on standard NIH receipt dates.